Home › NDC Lookup › RxCUI directory › RxCUI 756059

Lithium citrate 60 MG/ML Oral Solution — RxCUI 756059

RxNorm drug concept · Semantic clinical drug
RxCUI 756059 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI756059
Official nameLithium citrate 60 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslithium ion 8 MEQ per 5 ML Oral Syrup; lithium ion 8 MEQ in 5 mL Oral Solution; lithium citrate eqv to lithium carbonate 300 MG per 5 ML (lithium ion 8 MEQ per 5 ML) Oral Syrup
FDA products mapped13
Package NDCs mapped17
Reported Medicaid activity (SDUD)248,183 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Lithium citrate 60 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lithium citrate 60 MG/ML Oral Solution RxCUI 756059

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lithium citrate 52105
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lithium citrate Oral Solution 372619
    • Lithium citrate Oral Liquid Product 1163826
    • Lithium citrate Oral Product 1163827
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lithium citrate 60 MG/ML 332122

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lithium citrate 60 MG/ML SCDC · 332122
  • Lithium citrate Oral Solution SCDF · 372619
  • Lithium citrate Oral Liquid Product SCDG · 1163826
  • Lithium citrate Oral Product SCDG · 1163827

📦 FDA Products & Package NDCs

13 products · 17 package NDCs
17 package NDCs map to RxCUI 756059 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-2526-25 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0054-2526-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1987-01-28
00054-2527-25 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0054-2527-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1980-11-26
00054-2527-31 1000 CAPSULE, GELATIN COATED in 1 BOTTLE (0054-2527-31) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1980-11-26
00054-2531-25 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0054-2531-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1987-01-28
00054-4527-25 100 TABLET in 1 BOTTLE (0054-4527-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1982-01-29
00054-4527-31 1000 TABLET in 1 BOTTLE (0054-4527-31) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1982-01-29
00054-8526-25 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK (0054-8526-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1987-01-28
00054-8527-25 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK (0054-8527-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1980-11-26
00054-8528-25 10 TABLET in 1 BLISTER PACK (0054-8528-25) Lithium Carbonate Hikma Pharmaceuticals USA Inc. 1982-06-14
00121-1027-16 500 mL in 1 BOTTLE (0121-1027-16) Lithium PAI Holdings, LLC dba PAI Pharma 2026-04-14
00121-4027-94 3 TRAY in 1 CASE (0121-4027-94) / 10 CUP, UNIT-DOSE in 1 TR... Lithium PAI Holdings, LLC dba PAI Pharma 2026-04-14
68094-0077-62 3 TRAY in 1 CASE (68094-077-62) / 10 CUP, UNIT-DOSE in 1 TR... Lithium Precision Dose, Inc. 2025-10-24
70518-4227-00 10 CUP in 1 BOX (70518-4227-0) / 5 mL in 1 CUP (70518-4227-... Lithium REMEDYREPACK INC. 2024-11-04
70518-4227-02 10 CUP, UNIT-DOSE in 1 BOX (70518-4227-2) / 10 mL in 1 CUP,... Lithium REMEDYREPACK INC. 2024-11-05
71656-0072-16 473 mL in 1 BOTTLE (71656-072-16) Lithium Saptalis Pharmaceuticals, LLC 2024-04-05
71656-0072-50 5 TRAY in 1 CASE (71656-072-50) / 10 CUP in 1 TRAY / 5 mL i... Lithium Saptalis Pharmaceuticals, LLC 2024-03-28
72888-0172-46 500 mL in 1 BOTTLE (72888-172-46) Lithium Advagen Pharma Ltd 2022-11-09
Observed labelers: Hikma Pharmaceuticals USA Inc. (9) · PAI Holdings, LLC dba PAI Pharma (2) · REMEDYREPACK INC. (2) · Saptalis Pharmaceuticals, LLC (2) · Advagen Pharma Ltd (1) · Precision Dose, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.